Login / Signup

Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention.

Giuseppe DerosaAngela D'AngeloPaola PretiPamela Maffioli
Published in: Drug design, development and therapy (2020)
The chronic use (4 years) of a food supplement containing alpha lipoic acid is well tolerated, without significant differences between lower and higher dosages and improves glycemic status and lipid profile but only if administered at high dosage.
Keyphrases
  • clinical trial
  • type diabetes
  • study protocol
  • open label
  • phase ii
  • metabolic syndrome
  • double blind
  • weight loss
  • placebo controlled